MiNK Therapeutics Inc. Made Big Gain

Tue, Apr 12, 2022 at 05:30 PM

MiNK Therapeutics Inc. (INKT:NASDAQ) shot up at $3.18, a gain of 28.7%. The stock appeared on our News Catalysts scanner on Fri, Mar 18, 2022 at 10:04 AM in the 'INVESTOR UPDATE' category. From Tue, Mar 29, 2022, the stock recorded 44.44% Up Days and 50.00% Green Days

About MiNK Therapeutics Inc. (INKT:NASDAQ)

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other life-threatening...

Top 10 Gainers:

PolarityTE, Inc. (PTE:NASDAQ), 82.97%
Histogen Inc. (HSTO:NASDAQ), 67.78%
Qualigen Therapeutics Inc. (QLGN:NASDAQ), 53.62%
Agile Therapeutics, Inc. (AGRX:NASDAQ), 47.18%
TROOPS Inc. (TROO:NASDAQ), 31.29%
Vertical Aerospace Ltd. (EVTL:NYSE), 30.93%
MiNK Therapeutics Inc. (INKT:NASDAQ), 28.74%
Actinium Pharmaceuticals, Inc. (ATNM:NYSEMKT), 24.01%
Aterian Inc. (ATER:NASDAQ), 23.76%
Poema Global Holdings Corp. (PPGH:NASDAQ), 23.69%